Introduction {#s1}
============

Malaria parasites go through major transitions of differentiation as they cross tissue barriers of the mosquito with dramatic number changes [@pone.0089473-Mendes1]--[@pone.0089473-Blandin1]: between gametocytes and ookinetes, between ookinetes and mature oocysts, and between midgut and salivary gland sporozoites [@pone.0089473-Hillyer1]. The most critical bottleneck of *Plasmodium* development occurs during ookinete invasion of the midgut epithelium, prior to oocyst development on the basal lamina [@pone.0089473-Sinden1]. Digestive enzymes and mosquito defense proteins are partly responsible for the parasite loss at this stage [@pone.0089473-Michel1]--[@pone.0089473-Vlachou1]. The latter includes pathogen recognition proteins, serine proteases, phenoloxidases, antimicrobial peptides, and others.

External factors may also affect mosquito susceptibility to parasite infection, including ingested antibodies, subsequent blood feeding, and antimalarial drugs in blood meals. Among them, effects of antimalarial drugs on infectivity of parasites in mosquitoes are well documented. Chloroquine mainly targets *Plasmodium* at the erythrocytic stage. Nitroquine (CI-679 or 2,4-diamino-6-\[(3,4-dichlorobenzyl)nitros-amino\]quinazoline) caused nuclear and cytoplasmic damage in asexual forms of *P. berghei* and *P. cynomolgi* [@pone.0089473-Thompson1]. While there was no further report on this compound from Western countries, safety and efficacy of nitroquine were tested in rodents, chicken, primates, and humans [@pone.0089473-Group1]. Nitroquine is highly effective against *P. yoelii*, *P. gallinaceum*, and *P. cynomolgi* at the erythrocytic and exoerythrocytic stages. It interferes with structure and function of the cytoplasm and nucleus of *P. yoelii* exoerythrocytic forms [@pone.0089473-Chen1]. The action mechanism of nitroquine involves inhibition of *Plasmodium* DNA and protein synthesis [@pone.0089473-Pang1]--[@pone.0089473-Zhou1]. After further pharmacological and toxicological tests, nitroquine was used in clinical trials on malaria patients after 1973. In nine provinces and fifteen regions, this drug successfully cured 11,407 patients in the field tests [@pone.0089473-Group1]. Nitroquine and chloroquine were equally effective against *P. falciparum*. Chloroquine ingestion by mosquito at the time of blood feeding associates with an increase in parasite numbers in the insect host [@pone.0089473-Abrantes1]. In contrast, ingested nitroquine leads to a decrease in *Plasmodium* number and infectivity [@pone.0089473-Zhang1]. Using the model system of *Plasmodium yoelii* and *Anopheles stephensi*, we demonstrated that nitroquine induced transcription of a few mosquito genes encoding pattern recognition receptors, signal transducers, cell adhesion molecules, and oxidative stress proteins.

*An. stephensi* is a major malaria vector in the Indian subcontinent [@pone.0089473-Oshaghi1]. Rapid development and urbanization in this region has led to increase in the mosquito population resulting in frequent malaria epidemics [@pone.0089473-Dash1]. While recent malaria outbreaks occurred at a higher frequency, mortality became considerably lower. For example, during 2003, only 1006 of the reported 1.78 million cases in India caused deaths but reasons for the mortality reduction are unclear [@pone.0089473-Chatterjee1]. As an important disease vector, *An. stephensi* has not yet been intensively investigated at the molecular level, which hinders the elucidation of mechanisms for various physiological processes such as how immunity is possibly affected by nitroquine.

Although generation and analysis of cDNA clones from midgut tissue of adult female *An. stephensi* yielded useful sequences [@pone.0089473-Patil1], the acquired information is limited by the method used and additional experiments are needed to quantify their mRNA levels in different stages or tissues. Recently, a high throughput method is established to efficiently discover genes along with their expression profiles using next-generation sequencing technology [@pone.0089473-Zhang2]. Without resorting to a reference genome and thereby directly uncover process-related gene expression, the study revealed over 103 differentially regulated defense genes in *Manduca sexta*.

To better understand the impact of antimalarial drugs on mosquito's defense against *Plasmodium* parasites, we designed a study to discover genes with significantly altered mRNA levels in naïve versus *P. yoelii-*infected adult females of *An. stephensi* fed on nitroquine-treated or -untreated mice by the RNA-Seq approach. We largely increased the throughput of sequencing by adopting the Illumina technology and studied effects of the infection and drug on mosquito gene expression.

Methods and Materials {#s2}
=====================

Ethics Statement {#s2a}
----------------

This study was carried out in strict accordance with the recommendations in the Guide for the Ethics Committee of Third Military Medical University in China. The protocols involving mice were approved by the committee and performed under anesthesia to minimize suffering. Sodium pentobarbital was used to induce anesthesia.

Mosquitoes Rearing, Nitroquine Treatment, and P. yoelii Infection {#s2b}
-----------------------------------------------------------------

*An. stephensi* (Hor strain) mosquitoes were raised at 24°C, 75% humidity under a 12∶12 light-dark cycle and maintained on a 5% sucrose solution during adult stage. Female BALB/c mice were inoculated intraperitoneally with 200 µl of infected blood containing about 1×10^7^ *P. yoelii (*By265-GFP) parasitized erythrocytes obtained from a donor mouse with about 10% parasitemia. The course of infection was followed by examining Giemsa-stained blood smears prepared from tail blood samples collected at different times after inoculation. When the gametocitaemia reached 1%, a curative dose of nitroquine (12 mg/kg) was administered intragastrically to the mice. At 4 h after the drug treatment, gametocytaemia and parasite exagellation were confirmed. The female mosquitoes were fed on anesthetized mice for 2 h and collected at 24 h after blood feeding. Four-day-old adult females (25 per group) were allowed to blood fed on one of the following four groups: uninfected BALB/c mice treated with nitroquine (12 mg/kg) (UD, uninfected mice treated with nitroquine) for 4 h, *P. yoelii-*infected mice treated with the drug (12 mg/kg) (ID, infected mice treated with nitroquine) for 4 h, uninfected mice treated with buffer without nitroquine (UB, uninfected mice treated with buffer) for 4 h, or *P. yoelii*-infected mice treated with buffer only (IB, infected mice treated with buffer) for 4 h. Unfed mosquitoes were removed from the groups. The oocyst number in midgut was measured at 10 days post-blood feeding, and each assay was done with at least 25 mosquitoes, and the data represent three independent experiments. Difference of infection intensity between groups was analyzed by paired sample t-test (Prism 6.01, GraphPad Software, Inc.).

RNA Extraction, Library Construction and Sequencing, and Read Assembling {#s2c}
------------------------------------------------------------------------

Each of the four groups of female mosquitoes was collected 24 h after blood feeding, washed in ice-cold 95% ethanol to remove cuticle lipids, and rinsed in ice-cold water. All carcasses from the same group were combined, frozen in liquid nitrogen, and ground into fine powder for RNA extraction using TRIzol reagent (Invitrogen). mRNA was separately purified from the total RNA samples (1.0 mg each) by binding to cellulose in Mag-Bind mRNA Enrichment Kit (Omega Bio-Tek). For cDNA synthesis, mRNA was reverse transcribed with MMLV-RT (Promega) in the presence of oligo(dT)~15~ primer. Paired-end libraries were constructed from the four groups (UD, ID, UB, and IB) and sequenced at Macrogen Inc (Korea), following Illumina specifications. The four cDNA pools were sequenced on one lane for 101 cycles from both ends on Illumina GA-IIx HiSeq2000.

De Novo Assembly of Transcriptomes {#s2d}
----------------------------------

Filters were applied to remove low quality reads with \>33% N's (indetermination), \>33% A's from the 5′ end (or T's from the 3′ end) suggestive of poly-A tail, or \>34% nucleotides with low Phred quality scores (\<20 *i.e*. 1% error), according to Crawford et al [@pone.0089473-Crawford1]. After adaptor trimming, Velvet [@pone.0089473-Zerbino1] was employed to assemble the remaining reads in each of the four libraries at different hash lengths (*k*: 29, 35, 41). All contigs from the three exploratory assemblies were summarized by clustering using CD-HIT [@pone.0089473-Li1] to generate four datasets of UD, ID, UB, and IB. The default threshold of 90% was used as identity cutoff. In addition, all retained reads after filtration in the four libraries were assembled at four hash lengths (*k*: 21, 35, 49, 59). All contigs in the four exploratory sets were further assembled into one dataset designated "UIDB" (*k*: 39). Note that this "assembly of assemblies" may contain some misassembled contigs. The UIDB contigs were used as queries to search all insect sequences deposited at GenBank (<http://ncbi.nlm.nih.gov/>) and *An. stephensi* EST sequences [@pone.0089473-Patil1] using BLASTX and BLASTN at a cutoff E-value of 1×10^−5^. For discovering process-related genes by quantifying their mRNA level changes, numbers of the UD, ID, UB, and IB reads assembled into each UIDB contig were extracted from the Velvet output and tabulated using Microsoft Excel.

Read Normalization and Ratio Calculation {#s2e}
----------------------------------------

Read normalization and ratio calculation were performed as described by Zhang et al [@pone.0089473-Zhang2]. Briefly, based on frequencies of commonly used standards in each of the four libraries (*e.g*. number of rpS3 reads in UD ÷ number of total reads in UD), a set of six ribosomal protein genes were selected as internal standards, which had high total read numbers (\>10,000) and low coefficients of variation (*i.e*. SD/mean \<10%) in their frequencies. The sums of their read numbers for specific libraries, or library normalization factors (LNFs), which already reflected the differences in library sizes, were directly used to calibrate other read numbers in the corresponding libraries. For a specific contig in UIDB, its relative abundance (RA) in libraries X and Y is defined as: RA~x/y~ = (actual read \# in library X ÷ LNF~x~)/(actual read \# in library Y ÷ LNF~y~). In case read \# in library Y is zero, adjusted read number (ARN) is calculated as: ARN~x~ = actual read \# in library X × LNF~y~/LNF~x~. Some of the contigs in UIDB, whose RAs are above a threshold, are categorized as infection induced (UPi: RA~ID/UD~ or RA~IB/UB~ \>2), infection suppressed (DNi: RA~ID/UD~ or RA~IB/UB~ \<0.5), nitroquine induced (UPn: RA~ID/IB~ or RA~UD/UB~ \>2), and nitroquine suppressed (DNn: RA~ID/IB~ or RA~UD/UB~ \<0.5). These contigs were used as queries to search insect sequences including *An. stephensi* ESTs, as described in *Section 2.4*.

Quantitative Real-time PCR Analysis {#s2f}
-----------------------------------

Quantitative real-time PCR was performed to confirm the RNA-Seq expression profiling by using the same total RNA samples. Eight immunity-related genes were selected for validation of the expression data, including TEP1, APL1C, PGRP, FBN8, Eater, C-type lectin, CLIPC7, and SP ([Fig. S1](#pone.0089473.s001){ref-type="supplementary-material"}). Two cDNA samples from a similar experiment were examined by quantitative real-time PCR to further verify the RNA-Seq data. In that experiment, the female mosquitoes were fed on *P. yoelii*-infected mice or uninfected mice for 2 h and collected for RNA isolation at 24 h after blood feeding. Specific primers and SYBR Premix EX Taq (TaKaRa, Japan) was used in real-time PCR analysis on an ECO™ Real-Time PCR System (Illumina, USA). The reaction mixture (15 µl total volume) contained 7.5 µl 2×reaction buffer, 0.45 µl primers, 6.05 µl ddH~2~O and 1 µl cDNA template. The ribosomal protein S7 (rpS7) mRNA (GenBank AF539918) was used as an internal control for data normalization with the forward and reverse primers ([Fig. S1](#pone.0089473.s001){ref-type="supplementary-material"}).

Results and Discussion {#s3}
======================

1. Identification of Differentially Regulated Genes {#s3a}
---------------------------------------------------

To study the effect of *P. yoelii* infection (I) and nitroquine (D for drug) on *An. stephensi* gene transcription, we isolated mRNAs from adult female mosquitoes in the treatment (I and D) and control (U for uninfected, B for buffer) groups. Using oligo-dT primer annealing to the 3′ end of mRNA molecules, we generated four cDNA libraries: UD, ID, UB, and IB. To increase the read number and sequence coverage, we sequenced the libraries on an Illumina GA-IIx HiSeq2000. After removing ∼2% of the reads flagged as low quality or low complexity, we obtained a total of 25,505,495 reads from UD, 25,582,317 from ID, 22,561,525 from UB, and 21,145,138 from IB ([Table 1](#pone-0089473-t001){ref-type="table"}). We established 'exploratory' assemblies of the paired end reads in each library at three hash lengths.

10.1371/journal.pone.0089473.t001

###### Summary statistics for sequencing analysis of *An. stephensi* ESTs.

![](pone.0089473.t001){#pone-0089473-t001-1}

                                                UD                  ID           UB           IB      
  ---------------------------------- ------------------------- ------------ ------------ ------------ ---------
  Total number of reads                     25,505,495          25,582,317   22,561,525   21,145,138  
  de novo assembly (Velvet)                  *k* = 29             59,959       68,510       44,454     52,096
                                             *k* = 35             51,626       56,699       45,521     45,552
                                             *k* = 41             42,329       43,994       37,261     40,819
                                      Total number of contigs    153,914      169,203      127,236     138,467
  *k*: hash length                                                                                    
  contig size (avg./longest in bp)          630/18,654          567/12,990   705/14,638   665/16,526  
  Total BLASTable sequences                   52,813              59,731       41,121       46,350    

To quantify changes in gene expression, we also assembled reads from all the four groups into one set of contigs (UIDB) ([Table 2](#pone-0089473-t002){ref-type="table"}). First pass Velvet assemblies with hash length of 21 and 35 yielded 183,137 (N~50~: 231 bp, average size: 209 bp) and 206,003 (N~50~: 271 bp, average size: 230 bp) contigs, respectively. N~50~ value indicates that 50% of the contigs are equal to or longer than this length. Higher hash values of 49 and 59 yielded better assemblies with 85,946 contigs (N~50~: 752 bp, average size: 434 bp) and 48,422 contigs (N~50~: 1,275 bp, average size: 593 bp), respectively. Then we assembled the contigs obtained from these assemblies in a final summary assembly (*k*: 39) and resulted in a final dataset of 32,648 contigs (N~50~: 1819 bp, average size: 1,078 bp), and we have submitted the assembly of UIDB contigs to NCBI Sequence Read Archive database (<http://www.ncbi.nlm.nih.gov/Traces/sra_sub/sub.cgi?subid=180492&from=list&action=show>: submission) according to Submission Quick Start Guide. The BioProject, BioSample, and Experiment accession numbers are SRP029877, SRS478653 and SRX347875, respectively.

10.1371/journal.pone.0089473.t002

###### Summary iterative Velvet assembly UIDB.
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              contig number   total length (bp)   average size   N~50~ (bp)   total reads   unused reads
  ---------- --------------- ------------------- -------------- ------------ ------------- --------------
  *k* = 21       183,137         38,236,818          208.8          231       188,114,040   145,891,398
  *k* = 35       206,003         47,452,332          230.3          271                     120,165,694
  *k* = 49       85,946          37,272,482          433.7          752                      75,851,826
  *k* = 59       48,422          28,731,731          593.4         1,275                     66,483,158
  *k* = 39       32,648          35,182,144          1077.6        1,819        523,508       181,738

We extracted numbers of UD, ID, UB, and IB reads assembled into each UIDB contig. As read numbers directly correlated with library sizes and, therefore, had to be normalized first against control genes. Examination of the frequencies of commonly used internal standards in each of the four libraries resulted in a short list of six genes with low coefficients of variation (\<10%) and high total read numbers (\>10,000). We used the sums of their read numbers as library normalization factors (LNFs) to calibrate read numbers and calculate relative abundances (RAs). Based on the RA values, 3,046 or 9% of the 32,648 contigs in UIDB were categorized into four groups: infection induced, infection suppressed, nitroquine induced, and nitroquine suppressed. The total reads for each of the 3,046 contigs is greater than 1,000, so that low abundant transcripts (and, therefore, less reliable RA values) are eliminated from our study. To validate the RAs, we performed quantitative real-time PCR on eight genes using the same total RNA samples and found the fold changes were in good agreement in all these groups ([Fig. S1](#pone.0089473.s001){ref-type="supplementary-material"}). Similar results were obtained using cDNA samples from a different experiment. In the nitroquine induced and suppressed groups, we have found a total of 848 contigs. Among them, 550 contigs (65%) do not have BLAST hits and 111 are related to immunity, oxidative stress, detoxification, cytoskeleton assembling, or cell adhesion. In comparison, there are 2,198 contigs in the infection induced and suppressed groups: 1,806 (82%) have no BLAST hit and 109 are related to the above five processes. The low hit rates may stem from the cDNA synthesis and sequencing methods used.

The Illumina sequencing technology greatly increases read numbers and hence accuracy of RA values, but this comes at a cost. Short read length complicates their assembling into contigs with long coding regions that are highly desirable for species lacking sequenced genomes. Using random primers should alleviate this problem to certain extent, since they favorably bind to GC-rich coding sequences. In contrary, the oligo-(dT) primer causes a bias for contigs containing 3′ untranslated region, which contributes to the low BLAST hit rates of 18--35%. When the *An. stephensi* genome is published, we will overlay all our contigs to the gene models and expand the transcriptome search not only to the groups studied here but also to other processes affected by the drug or infection.

2. Sequence Analysis and Function Prediction of Nitroquine-induced Genes {#s3b}
------------------------------------------------------------------------

We discovered 356 UIDB contigs whose RA~ID/IB~ or RA~UD/UB~ values were higher than 2. As anticipated, some of these contigs encoded polypeptides either similar to defense proteins identified in *An. gambiae*, *Aedes aegypti*, *Culex quinquefasciatus* and other insects (*e.g*. *Drosophila melanogaster*) ([Table 3](#pone-0089473-t003){ref-type="table"}), or related to proteins previously not known to participate in immune responses, or having no significant sequence similarity to known proteins. In the following sections, we describe them in the order of their putative functions.

10.1371/journal.pone.0089473.t003

###### A list of 51 nitroquine-induced contigs for pathogen recognition, signal transduction, oxidative stress, detoxification, cytoskeleton, and cell adhesion proteins.
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  CIFH contig                                                Original read\#   RA~ID/IB~   RA~UD/UB~   BLAST results                                
  --------------------------------------------------------- ----------------- ----------- ----------- --------------- ----------- --------- ------- ------------------------------------------------
  **Pathogen recognition**                                                                                                                          
  26579                                                            238            18          15             8         ***279***    2.25     15.87           gb\|ADZ44774.1\| APL1C \[Ag\]
  25888                                                            100            76          19            35         ***230***    2.17     5.26           gb\|EAA09703.2\| SR CD36 \[Ag\]
  38607                                                           2929           1478        1390           551          6348       2.68     2.11           gb\|EAU75744.2\| LRR pr. \[Ag\]
  695                                                             2356           1727         859          1150          6092       1.50     2.74           gb\|EAL41884.2\| LRR pr. \[Ag\]
  51750                                                           1916           1904         944          1782          6546       1.07     2.03           gb\|EAA10783.4\| LRR pr. \[Ag\]
  12975                                                           1459           2039         580           707          4785       2.88     2.52             gb\|ACG68523.1\| TEP1 \[Ag\]
  **Extracellular and intracellular signal transduction**                                                                                           
  38768                                                           6544           5141        2952          3024          17661      1.70     2.22             emb\|CAA93818.1\| SP \[Ag\]
  19862                                                           2057           1178         810           824          4869       1.43     2.54       gb\|EAA01781.5\| carboxypeptidase \[Ag\]
  37858                                                            79             44           4            30         ***157***    1.47     19.75             gb\|EAA00311.5\| SP \[Ag\]
  13513                                                            57              9           6            28         ***100***    0.32      9.5         gb\|EDS27643.1\| SP rhomboid \[Cq\]
  3479                                                            4949           2874        2261          1304          11388      2.20     2.19         gb\|EAA14916.1\| SP inhibitor \[Ag\]
  35090                                                           3823           3549        1888          2235          11495      1.59     2.02              gb\|EDS26829.1\| SP \[Cq\]
  22997                                                           1036            720         394           338          2488       2.13     2.63              gb\|AAC02700.1\| SP \[Ag\]
  12130                                                            948           1271         367           421          3007       3.02     2.58             emb\|CAA80512.1\| SP \[Ag\]
  2706                                                             301           2168        1069           170          3708       9.34     0.29          gb\|EAA08853.4\| clip SP C7 \[Ag\]
  16368                                                            998            725         463           650          2836       1.12     2.13        gb\|EAA14062.4\| ANK repeat pr. \[Ag\]
  11526                                                            342            67          67            43            519       1.56     5.10        gb\|EAA05854.4\| ANK repeat pr. \[Ag\]
  3861                                                             106            43          18            56         ***223***    0.77     5.89      gb\|ABD83643.1\| G-nucleotide fact. \[Dm\]
  12518                                                             5             58          73             0         ***136***   42.49\*   0.09         gb\|EAA00858.4\| G protein β2 \[Ag\]
  4877                                                             16             34          49             4         ***103***    6.23     0.33        gb\|AAF52759.2\| G protein γ30A \[Dm\]
  16565                                                           1274            802         637           866          3579       0.93     2.00           gb\|EAA09222.5\| spectrin \[Ag\]
  517                                                              130            835        1525           31           2521       19.73    0.09      gb\|EAA10755.2\| arrestin 2 protein \[Ag\]
  3493                                                             76             373        1002           16           1467       17.08    0.08           gb\|AAG54081.1\| arrestin \[Ag\]
  **Oxidative stress and detoxification**                                                                                                           
  57082                                                           1825            852         669           285          3631       2.99     2.73    gb\|EDS38768.1\| sorbitol dehydrogenase \[Cq\]
  12429                                                             0             164          0            17         ***181***    7.06      --       gb\|ABK97426.1\| 14-3-3 epsilon pr. \[Bm\]
  30351                                                            137             5          12             3         ***157***    1.67     11.42      gb\|EDS33498.1\| cytochrome P450 \[Cq\]
  10946                                                           5719           4859        2504          4616          17698      1.05     2.28       gb\|EAT44585.1\| cytochrome P450 \[Aa\]
  24943                                                           2606           1402        1150           709          5867       2.00     2.27       gb\|EAA15034.4\| cytochrome P450 \[Ag\]
  **Cytoskeleton and cell adhesion**                                                                                                                
  6349                                                             18             76          17             9         ***120***    6.18     1.08      gb\|EDO63457.1\| TGF-β-induced pr. \[Ag\]
  7935                                                             43             36          18             5         ***102***    5.28     2.44            gb\|EAA00824.1\| nexin \[Ag\]
  16374                                                            56             26           5            35         ***122***    0.74     11.2        gb\|ACO90373.1\| myosin H-chain \[Bm\]
  33424                                                            47             40           6            17         ***110***    2.35     7.83          ref\|XP_970252.2\| formin 3 \[Dw\]
  5709                                                             359            209         52            164           784       1.27      6.9    gb\|EFN64027.1\| myosin L-chain kinase \[Ag\]
  21446                                                            35             34           7            34         ***110***    1.03     5.10    gb\|EFN83270.1\| myosin L-chain kinase \[Ag\]
  16802                                                           9136           6160        4221          5875          25392      1.05     2.16        gb\|EAT42759.1\| myosin H-chain \[Ag\]
  484                                                             9150           6315        3661          5270          24396       1.2      2.5            gb\|EAT46230.1\| titin \[Aa\]
  39386                                                           5590           3493        1758          3235          14076      1.08     3.18        gb\|EAT42858.1\| myosin H-chain \[Ag\]
  722                                                             5514           3851        1642          3053          14060      1.26     3.36    gb\|EAT43208.1\| myosin L-chain kinase \[Aa\]
  6836                                                            3941           2753        1950          2339          10983      1.18     2.02       gb\|EAT36995.1\| paramyosin, long \[Aa\]
  19562                                                           1886           1183         628          1210          4907       0.98     3.06        gb\|EAT42758.1\| myosin H-chain \[Ag\]
  39406                                                           1322            824         459           820          3425       1.00     2.88        gb\|EAT42758.1\| myosin H-chain \[Ag\]
  49526                                                           1383            513         377           650          2923       0.79     3.67        gb\|EAT42758.1\| myosin H-chain \[Ag\]
  48089                                                           1225            802         395           778          3200       1.03     3.10        gb\|EDS44962.1\| myosin H-chain \[Cq\]
  16375                                                           1160            782         368           694          3004       1.13     3.15        gb\|EAT42758.1\| myosin H-chain \[Ag\]
  14623                                                            863            794         404           747          2808       1.06     2.14      gb\|EAT43213.1\| titin (connectin) \[Aa\]
  2492                                                             820            579         398           441          2238       1.31     2.06          gb\|EAT39116.1\| gliotactin \[Aa\]
  14852                                                            953            484         210           470          2117       1.03     4.54            gb\|EEB13142.1\| titin \[Phc\]
  5828                                                             52             34           8            22         ***116***    1.55     6.50           gb\|EAT48765.1\| cadherin \[Aa\]
  2452                                                            10325          6671        4525          7264          28785      0.94     2.28            gb\|EAT45935.1\| kakapo \[Aa\]
  302                                                             1132            527         553           802          3014       0.66     2.05           emb\|CAA09870.1\| kakapo \[Dm\]

The total read numbers, if lower than 300, are shown in italic and bold so that their RAs need to be interpreted with caution. \*:adjusted read number (ARN). The footnote also applies for [Tables 4](#pone-0089473-t004){ref-type="table"}--[6](#pone-0089473-t006){ref-type="table"}.

### 2.1. Pattern Recognition Receptors (PRRs) {#s3b1}

Immune reactions are initiated when microbial surface molecules are recognized as "non-self" by PRRs that bind to pathogen-associated molecular patterns. For example, we found contig 26579 (RA~ID/IB~: 2.25, RA~UD/UB~: 15.87) encode a leucine-rich repeat (LRR) protein homologous to APL1C ([A]{.ul}nopheles [P]{.ul}lasmodium-responsive [L]{.ul}RR protein-[1C]{.ul}). There are three other LRR protein contigs (51750, 38607, 695) and one thioester-containing protein (TEP) contig (12975: RA~ID/IB~: 2.88, RA~UD/UB~: 2.52). An. gambiae encodes 24 members of the LRR protein family named LRIMs (for leucine-rich repeat immune proteins). Two of them, LRIM1 and APL1C, are components of a mosquito complement-like system crucial for defense against Plasmodium parasites [@pone.0089473-Povelones1]. LRIM1 and APL1C circulate in the hemolymph exclusively as a disulfide-bonded complex that specifically interacts with the mature form of a complement C3-like protein, TEP1 [@pone.0089473-Rottschaefer1]--[@pone.0089473-Baxter1]. Other recognition proteins include scavenger receptors (SRs, contig 25888, RA~ID/IB~: 2.17, RA~UD/UB~: 5.26). Comparative genomics studies have revealed four orthologs of this receptor in An. gambiae. Knockdown of Croquemort SCRBQ2 expression by dsRNA injection resulted in a 62.5% reduction in oocyst formation, suggesting that this SR plays a key role in Plasmodium-mosquito interactions [@pone.0089473-GonzlezLzaro1]--[@pone.0089473-Nichols1].

### 2.2. Extracellular signal modulators {#s3b2}

Recognition of non-self usually activates an extracellular cascade of serine proteases (SPs) that amplifies the signal and triggers downstream responses to kill the invaders [@pone.0089473-Osta1]. We found six SP contigs induced by nitroquine: contigs 38768, 37858, 13513, 35090, 22997, and 12310. SPs share a catalytic mechanism and structural characteristics including three conserved catalytic residues (His, Asp, Ser). Genome annotation of SPs and noncatalytic SPHs (H for homolog) in An. gambiae, D. melanogaster, Homo sapiens, and Fugu rubripes have identified 305, 206, 110, and 125 such genes, respectively [@pone.0089473-Zdobnov1]. Reverse genetic analyses of several SPs/SPHs demonstrated their importance in mediating melanization, killing, and disposal of malaria parasites in An. gambiae [@pone.0089473-Volz1]--[@pone.0089473-Paskewitz1].

Key components of the protease cascades include clip-domain SPs/SPHs (CLIPs), which take part in several defense mechanisms in insects and crustaceans such as the activation of signaling pathways leading to the synthesis of antimicrobial peptides [@pone.0089473-Ligoxygakis1], hemolymph coagulation [@pone.0089473-Huang1], and melanization [@pone.0089473-Kanost1]. We identified a nitroquine-induced homolog of *A. gambiae* CLIPC7 (contig 2706). So far, *An. gambiae* CLIPB14 and CLIPB15 are found to be responsive to bacterial or *Plasmodium* infection: B14 showed persistent up-regulation in *Plasmodium-*infected mosquitoes while B15 showed transient up-regulation during midgut invasion [@pone.0089473-BarillasMury1]--[@pone.0089473-Mwangi1]. Signal transduction mediated by extracellular SP pathways is down regulated by serpins, which are irreversible, suicide inhibitors that covalently bind to the active site Ser of their target SPs [@pone.0089473-Kanost2]. We have identified one nitroquine-induced serpin (contig 3479).

### 2.3. Intracellular signal transducers {#s3b3}

Intracellular immune signaling pathways transmit the alarm signal originated from pathogen- associated PRRs to effector genes. We found two ankyrin repeat protein (ANK) contigs (16368, 11526). Ankyrin repeat is a 33-residue motif often occurring in tandem arrays that cooperatively fold into structures for molecular recognition via protein interactions. *An. gambiae* REL2 (a Relish homolog containing an ANK domain) regulates expression of antimicrobial peptide genes cec1, cec3, and gam1 [@pone.0089473-Meister1]. Spectrins are components of G-protein coupled receptor (GPCR) and synaptic multi-protein complexes involved in cell cycle by regulating expression of membrane receptors [@pone.0089473-Machnicka1]. Invertebrates have a small repertoire of spectrin genes. We found aspectrin (contig 16565), G-protein components (contigs 12518 and 4877), as well as arrestins (contigs 517 and 3493). Arrestins mediate cellular processes via interactions with secondary signal transduction cascades by means of recruiting and activating mitogen-activated protein kinase (MAPK) and other effectors [@pone.0089473-Lefkowitz1]--[@pone.0089473-Gurevich1]. Other intracellular proteins possibly involved in signal transduction or modulation include a GTP/GDP exchange factor.

### 2.4. Oxidative stress and detoxification proteins {#s3b4}

Several genes for oxidative stress and detoxification were up-regulated by nitroquine, including sorbitol dehydrogenase (contig 57082, RA~ID/IB~: 2.99, RA~UD/UB~: 2.73), 14-3-3 epsilon protein (contig 12429), three cytochrome P450 contigs (30351, 10946, 24943).

### 2.5. Cytoskeleton and cell adhesion molecules {#s3b5}

Cytoskeletal dynamics and remodeling are considered as key factors affecting P. berghei invasion of the mosquito midgut [@pone.0089473-Abrantes1]. Nitroquine affected the expression of some cytoskeletal and adhesion proteins. A highly conserved, transforming growth factor (TGF) -β inducible matrix protein (contig 6349, RA~ID/IB~: 6.18) may be a bifunctional linker between individual matrix components and resident cells [@pone.0089473-Billings1]. Six innexin genes in *Ae. aegypti* are closely related to their *Drosophila* homologs, suggesting critical roles of gap junctions in diverse cellular and tissue functions [@pone.0089473-Weng1]. We identified an innexin gene (contig 7935, RA~ID/IB~: 5.28, RA~UD/UB~: 2.44) in An. stephensi, which was highly induced after the drug treatment. A putative formin (contig 33424, RA~ID/IB~: 2.35, RA~UD/UB~: 7.83) may govern microtubule and microfilament dynamics by functioning as an effector of ρ small GTP-binding proteins during cell adhesion, cytokinesis, polarization, and morphogenesis [@pone.0089473-Tour1]. Titin (contigs 484, 14623, and 14852), the third most abundant protein in muscle (after actin and myosin), is responsible for much of the myofibril elasticity in various organisms. Titin molecules are associated with each thick filament in skeletal muscle, where they interact with myosin [@pone.0089473-Fabian1]. Ten myosin contigs were up-regulated ([Table 3](#pone-0089473-t003){ref-type="table"}). Gliotactin (contig 2492), first identified in the tricellular junction, is necessary for the development of tricellular junction and septate junctions [@pone.0089473-PadashBarmchi1]. Cadherin (contig 5828, RA~UD/UB~: 6.50) is a cell surface glycoprotein that may act as a receptor for envelop proteins of dengue or West Nile viruses when they enter mosquito cells [@pone.0089473-Colpitts1]. Two kakapo protein contigs (2452, 302) encode a giant cytoskeleton protein that has multiple isoforms with characteristics of the spectrin and plakin superfamilies. Previously characterized short isoforms are similar to spectrin and dystrophin with an actin-binding domain followed by spectrin repeats [@pone.0089473-Rper1].

3. Nitroquine-suppressed Genes {#s3c}
------------------------------

We further analyzed the 492 contigs down-regulated by nitroquine. Among the 158 (32%) with BLAST hits, 60 contigs were related to defense responses ([Table 4](#pone-0089473-t004){ref-type="table"}). These include two PGRP contigs (42111, RA~UD/UB~: 0.12; 42110, RA~UD/UB~: 0.16). PGRPs are soluble or membrane- bound proteins with a domain similar to T7 lysozyme that hydrolyzes bacterial peptidoglycans 4-[@pone.0089473-Christophides1]. We also found three fibrinogen-related protein (FREP) contigs (54250, 9243, 6608). FREPs belong to an evolutionarily conserved gene family in mammals and invertebrates. *An. gambiae* has as many as 59 FREPs whereas *D. melanogaster* only has 14 [@pone.0089473-Dong2]. A majority of these genes display immune-responsiveness after challenge with bacteria, fungi or *Plasmodium,* and their expression patterns correlate strongly with gene phylogeny and chromosomal location. We identified two putative Eater contigs (9561, 4173). In the fruit fly, this SR with epidermal growth factor-like repeats is produced by phagocytes and required to survive after Gram-positive or -negative bacterial infection [@pone.0089473-Chung1]. Among the nitroquine-suppressed genes, there are eight prophenoloxidase (PPO) contigs (13019, 7548, 18477, 24062, 24063, 3605, 3163, 29061) ([Table 4](#pone-0089473-t004){ref-type="table"}). It is generally accepted that insect phenoloxidases (POs) are synthesized as inactive PPOs that undergo limited proteolysis by specific SPs to become active. Insect POs are key enzymes causing melanization around invading pathogens and at wounds to prevent infection [@pone.0089473-Gorman1]. We also found six SP contigs (700, 13660, 10250, 47533, 20619, 47687) and one defensin contig (22126, RA~UD/UB~: 0.20). Additionally, we identified ten down-regulated genes related to oxidative stress and detoxification: two NADH dehydrogenase contigs 19543 and 21976, five cytochrome oxidase contigs (26093, 37377, 12844, 12660, 37606), peroxidase contig 38629, esterase A11 contig 49194, and carboxylesterase contig 2792.

10.1371/journal.pone.0089473.t004

###### A list of 60 nitroquine-suppressed contigs for pathogen recognition, signal transduction, effector, oxidative stress, detoxification, cytoskeleton, and cell adhesion proteins.

![](pone.0089473.t004){#pone-0089473-t004-4}

  UIDB contig                                                Original read\#   RA~ID/IB~   RA~UD/UB~   Blast results                            
  --------------------------------------------------------- ----------------- ----------- ----------- --------------- ----------- ------ ------ ------------------------------------------------
  **Pathogen recognition**                                                                                                                      
  9561                                                             56             88          42            132           318      0.49   1.37           gb\|ADK20118.1\| Eater \[Dm\]
  4173                                                             150            93          71            139           453      0.49   2.17           gb\|ADK20124.1\| Eater \[Dm\]
  42111                                                            33             95          287           94            509      0.74   0.12            gb\|ADA54914.1\| PGRP \[Aa\]
  42110                                                            126            505         785           475          1891      0.78   0.16            gb\|ACI30152.1\| PGRP \[Ad\]
  54250                                                             7             45          32            23         ***107***   1.45   0.22            gb\|ADC29801.1\| FBN8 \[Ag\]
  6608                                                             35             136         76            164           411      0.61   0.47   gb\|EAT36947.1\| fibrinogen/fibronectin \[Aa\]
  9243                                                             192            230         112           448           982      0.38   1.75            gb\|ADF80532.1\| FBN9 \[Ag\]
  1559                                                             35             24          41            36         ***136***   0.87   0.49           gb\|EFN79581.1\| SR-B1 \[Hs\]
  **Extracellular and intracellular signal transduction**                                                                                       
  700                                                              166            181         82            300           729      0.44   2.08             gb\|EAT40468.1\| SP \[Aa\]
  13660                                                             9             43          23            34         ***109***   0.40   0.93             gb\|EDS40340.1\| SP \[Cq\]
  10250                                                            227            635         580           339          1781      1.39   0.40              gb\|EAT33372.1\| SP \[Aa
  47533                                                            251            569         570           199          1589      2.08   0.45            gb\|ACN38211.1\| SP14 \[Ag\]
  20619                                                           1506           1721         960          2533          6720      0.50   1.61          gb\|EDS32243.1\| SP nudel\[Cq\]
  47687                                                            36             186         83            46            351      2.94   0.44            gb\|ACN38197.1\| SP14 \[Ag\]
  4825                                                             31             17          32            33         ***113***   0.38   1.00           gb\|EAT43503.1\| MRAS2 \[Aa\]
  32102                                                            55             28          39            52         ***174***   0.40   1.45        gb\|EAT33735.1\| G nucleotide-BP β3
  25178                                                            40             43          15            67         ***165***   0.47   2.78        gb\|AAF53349.2\| centaurinγ1A \[Dm\]
  28679                                                            412            205         286           319          1222      0.47   1.47     gb\|EAT42068.1\| microtubule kinase \[Aa\]
  8919                                                             41             23           6            34         ***104***   0.50   7.69   gb\|EAT37086.1\| netrin receptor (unc5) \[Aa\]
  31670                                                            14             49          198           34         ***295***   1.06   0.07            gb\|AAV84215.1\| EF1α \[Cs\]
  698                                                             65408          69153      155352         79238        369151     0.64   0.43    gb\|EDS27326.1\| GH regulated TBC pr1 \[Cq\]
  2295                                                             22             69          46            29         ***166***   1.75   0.49          gb\|EDS27643.1\| rhomboid \[Cq\]
  46422                                                            66             24          24            59         ***173***   0.30   2.86       gb\|EDS25690.1\| GTP-BPα, gnao \[Cq\]
  **Effectors**                                                                                                                                 
  22126                                                           1986           6575        9960          4674          23195     0.97   0.20          gb\|ABB00946.1\| defensin \[Ag\]
  13019                                                            18             29          38            49         ***134***   0.43   0.49            gb\|AAC69182.1\| PPO \[As\]
  7548                                                             96             253         124           598          1071      0.31   0.81            gb\|AAB94672.1\| PPO3 \[Ag\]
  18477                                                            56             106         58            247           467      0.31   0.99            gb\|AAB94672.1\| PPO3 \[Ag\]
  24062                                                            68             181         91            401           741      0.33   0.76            gb\|AAB94672.1\| PPO3 \[Ag\]
  24063                                                            114            254         184           521          1073      0.36   0.63            gb\|AAB94672.1\| PPO3 \[Ag\]
  3605                                                             41             79          48            162           330      0.36   0.88            gb\|AAB94672.1\| PPO2 \[Ag\]
  3163                                                             877           1681        1034          3172          6764      0.39   0.87            gb\|EAA10430.2\| PPO9 \[Ag\]
  29061                                                            117            121         53            217           508      0.41   2.27            gb\|AAD01936.1\| PPO \[Ag\]
  **Oxidase stress and detoxification**                                                                                                         
  19543                                                            43             11          26            102        ***182***   0.11   1.20         gb\|ADE18217.1\| NADH DH-4 \[Bm\]
  26093                                                            54             20          35            124        ***233***   0.17   1.14    gb\|ACG59301.1\| cytochr. C oxidase-3 \[Gp\]
  37377                                                            132            28          82            149           391      0.19   1.18     gb\|ABV71224.1\| cytochr. oxidase-2 \[Dt\]
  21976                                                            15             12          26            61         ***114***   0.20   0.42         gb\|ADO60622.1\| NADH DH-1 \[Of\]
  12844                                                            44             18          28            61         ***151***   0.30   1.15         gb\|ABH03691.1\| cytochr. b \[Cd\]
  12660                                                            190            88          141           223           642      0.40   0.99    gb\|AAT69281.1\| cytochr. c oxidase-1 \[Td\]
  37606                                                           1129            411        1241           991          3772      0.42   0.67     gb\|ABF18100.1\| cytochr. c oxidase\[Aa\]
  38629                                                            57             24          66            51         ***198***   0.48   0.63       gb\|AAV30070.1\| peroxidase 4A \[Ag\]
  49194                                                            46             20          36            40         ***142***   0.37   1.32        gb\|ABO85014.1\| esterase A11 \[Cq\]
  2792                                                             313            288         195           474          1270      0.45   1.64     gb\|EDS29180.1\| carboxylesterase 3 \[Cq\]
  **Cytoskeleton and cell adhesion**                                                                                                            
  4610                                                             57             14          22            43         ***136***   0.24   2.70           gb\|EDS37841.1\| kakapo \[Cq\]
  17301                                                            72             14          28            41         ***155***   0.25   2.63           gb\|EFN61557.1\| NCAM2 \[Cf\]
  27643                                                            78             11          17            31         ***137***   0.26   4.76           gb\|AAN10358.5\| dumpy \[Dm\]
  52735                                                            33             18          18            38         ***107***   0.35   1.89          gb\|EAT36301.1\| perlecan \[Aa\]
  2620                                                             100            54          119           98            371      0.40   0.86          gb\|EDS31391.1\| cadherin \[Cq\]
  24227                                                            153            42          31            67         ***293***   0.46   5.26           gb\|EDS41643.1\| dumpy \[Cq\]
  44130                                                            160            124         75            184           543      0.50   2.17          gb\|EAT36301.1\| perlecan \[Aa\]
  37846                                                            63             30          29            44         ***166***   0.50   2.22          gb\|EAT48357.1\| cadherin \[Aa\]
  35484                                                            27             20          18            46         ***111***   0.32   1.54   gb\|EAT42208.1\| paraflagellar rod pr. \[Aa\]
  8549                                                             55             25          35            52         ***167***   0.35   1.61         gb\|EDS28887.1\| myosin III \[Cq\]
  11346                                                            62             57          41            106        ***266***   0.40   1.54    gb\|EDS31801.1\| rab6 activating pr. \[Cq\]
  6175                                                             50             26          39            39         ***154***   0.49   1.32         gb\|AAX52757.1\| formin 3A \[Dm\]
  46683                                                            12             59          62            60         ***193***   0.72   0.20           gb\|EDS37500.1\| actin \[Cq\]
  18610                                                            24             119         109           62            314      1.41   0.23           gb\|EAT38677.1\| actin \[Aa\]
  24214                                                            26             59          58            52         ***195***   0.83   0.46           gb\|EDS37500.1\| actin \[Cq\]
  10559                                                            24             21          50            21         ***116***   0.74   0.49           gb\|AAV65298.1\| actin \[Ag\]
  36525                                                            45             74          183           67            369      0.81   0.25          gb\|EAT34065.1\| actin BP \[Aa\]
  5097                                                             53             13          79            31         ***176***   0.68   0.31          gb\|EFN75894.1\| whirlin \[Hs\]

In the previous study [@pone.0089473-Zhang1], at five days post-feeding on *P. yoelii* infected mice, mosquitoes were continually fed on 0.1% nitroquine in sucrose solution prior to collection at 7, 9, and 13 days post infection for morphology, PCR, and PO activity tests. Under those conditions, we observed melanized oocysts and an increase in PPO mRNA levels in the nitroquine-treated mosquitoes. Here, we administered the drug to *P. yoelii*-infected mice at a dosage similar to that for people in malaria endemic areas, but did not observe melanized ookinetes and detected a decrease in PPO mRNA levels. A likely reason for the discrepancy is the low dosage and no drug administration after the blood meal, which caused a milder immune response that hampered but did not completely block the parasite development. There was no clear difference in gametocyte number or morphology between the ID and IB groups after treatment (data not shown). Nonetheless, we detected significant decrease in median oocyst count at 10 days post- blood feeding ([Fig. S2](#pone.0089473.s002){ref-type="supplementary-material"}), indicating that pre-oocyst stages (including those in mouse) were affected by low dosage of nitroquine but stayed viable for a period of time. After all, nitroquine did cause complex changes in gene expression.

4. Genes Induced by Plasmodium Infection {#s3d}
----------------------------------------

### 4.1. Pattern recognition receptors {#s3d1}

While mRNA levels are up- or down- regulated after nitroquine treatment, we also examined how parasite infection may affect transcription ([Tables 5](#pone-0089473-t005){ref-type="table"} and [6](#pone-0089473-t006){ref-type="table"}) and identified overlaps with the contigs in [Tables 3](#pone-0089473-t003){ref-type="table"} and [4](#pone-0089473-t004){ref-type="table"}. Two FREP contigs (54250, RA~ID/UD~: 5.99; 9243, RA~IB/UB~: 5.20) and one Eater (contig 9561) were up-regulated in infected mosquitoes but down-regulated in drug-treated ones. We found one C-type lectin (contig 4534), one complement 4b-like protein (contig 4650), and one TEP (contig 13138). The A. gambiae genome contains 19 TEP genes [@pone.0089473-Christophides1]. TEP1 is a typical one characterized in some detail [@pone.0089473-Levashina1]. It is unclear whether all mosquito TEPs are engaged in similar functions. An. gambiae *TEP3* and *TEP4* are up-regulated upon bacterial challenge or parasite infection [@pone.0089473-BouAoun1]. Two LRR protein contigs (2407 and 4502) had RA~IB/UB~ of 2.07 and 2.38, respectively.

10.1371/journal.pone.0089473.t005

###### A list of 89 infection-induced contigs for pathogen recognition, signal transduction, effector, oxidative stress, detoxification, cytoskeleton, and cell adhesion proteins.

![](pone.0089473.t005){#pone-0089473-t005-5}

  UIDB contig                                                Original read\#   RA~ID/UD~   RA~IB/UB~   Blast results                                   
  --------------------------------------------------------- ----------------- ----------- ----------- --------------- ----------- ---------- --------- -------------------------------------------------
  **Pathogen recognition**                                                                                                                             
  54250                                                             7             45          32            23         ***107***     5.99      0.93              gb\|EAA00222.4\| FBN8 \[Ag\]
  9243                                                             192            230         112           448           982        1.11      5.20               gb\|AAR13732.1\| FBN \[Ag\]
  9561                                                             56             88          42            132           318        1.46      4.08              gb\|ADK20118.1\| Eater \[Dm\]
  13138                                                            61             59          22            37         ***179***     0.90      2.18              gb\|AAM52596.1\| TEP2 \[Dm\]
  4650                                                             505            458         272           526          1761        0.85      2.51       gb\|EDS39639.1\| c4b-binding protein \[Cq\]
  7569                                                             555            462         272           523          1812        0.77      2.50              gb\|ADK20110.1\| Eater \[Dm\]
  4534                                                             221            265         191           298           975        1.11      2.03          gb\|EAA08886.5\| C-type lectin \[Ag\]
  2407                                                             253            500         177           282          1212        1.84      2.07               gb\|EAT46201.1\| LRR \[Aa\]
  4502                                                             208            281         158           290           937        1.26      2.38               gb\|EDS45577.1\| LRR \[Cq\]
  **Extracellular and intracellular signal transduction**                                                                                              
  479                                                              382           1216         650          1442          3690        2.96      2.89               gb\|EAT45655.1\| SP \[Aa\]
  2792                                                             313            288         195           474          1270        0.86      3.15       gb\|EDS29180.1\| carboxylesterase 3 \[Cq\]
  20619                                                           1506           1721         960          2533          6720        1.07      3.43               gb\|EDS32243.1\| SP \[Cq\]
  2323                                                             960           1006         581          1148          3695        0.98      2.57                gb\|EDS32243.1\| SP\[Cq\]
  41006                                                            799            903         507           806          3015        1.05      2.07       gb\|AAS99341.1\| carboxypeptidase B \[Ag\]
  14021                                                            722           1425         369           870          3386        1.84      3.06       gb\|EDS33630.1\| carboxypeptidase A1 \[Cq\]
  17844                                                             0             109          0            30         ***139***    101.59     38.98        gb\|EDW63808.1\| G nucleotide-BP \[Dv\]
  3643                                                             123            427         67            604          1221        3.23      11.71      gb\|AAF48160.3\| protein kinase Cδ-C \[Dm\]
  8154                                                             477            446         218           383          1524        0.87      2.28             gb\|EAA14062.4\| ANK pr. \[Ag\]
  13991                                                            617            984         487          1158          3246        1.49      3.09               gb\|AAF49192.2\| MAPK\[Dm\]
  18201                                                            383            693         303           543          1922        1.69      2.33            gb\|EDS30611.1\| caspase-2 \[Cq\]
  4898                                                             315            367         184           295          1161        1.09      2.08             gb\|EAT33004.1\| ankyrin \[Aa\]
  21463                                                            348            299         145           331          1123        0.80      2.96              gb\|EDW32992.1\| GPCR \[Dp\]
  **Effectors**                                                                                                                                        
  22126                                                           1986           6575        9960          4674          23195       3.09      0.60            gb\|ABM92299.1\| defensin \[As\]
  7548                                                             96             253         124           598          1071        2.45      6.26               gb\|AAC69182.1\| PPO \[As\]
  10561                                                            365            399         309           583          1656        1.02      2.45               gb\|EDS44938.1\| PO1 \[Cq\]
  24062                                                            68             181         91            401           741        2.48      5.72              gb\|AAB94672.1\| PPO2 \[Ag\]
  18477                                                            56             106         58            247           467        1.76      5.53               gb\|AAO22166.1\|PPO \[Ac\]
  29061                                                            117            121         53            217           508        0.96      5.31               gb\|AAD01936.1\| PPO \[Ag\]
  24063                                                            114            254         184           521          1073        2.08      3.67              gb\|AAB94672.1\| PPO2 \[Ag\]
  39231                                                            72             128         76            169           445        1.67      2.88               gb\|AF062034.1\| PPO \[As\]
  3605                                                             41             79          48            162           330        1.80      4.38             gb\| AAF57775.1\| PPO-A1 \[Dm\]
  3163                                                             877           1681        1034          3172          6764        1.78      3.98              gb\|EAA10430.2\| PPO9 \[Ag\]
  **Oxidative stress and detoxification**                                                                                                              
  37606                                                            411           1129         991          1241          3772        2.56      1.62       gb\|ABF18100.1\| cytochr. c oxidase \[Aa\]
  10946                                                           5719           4859        2504          4616          17698       0.79      2.39          gb\|EAT44585.1\| cytochr. P450 \[Aa\]
  12511                                                            351            428         181           382          1342        1.13      2.74          gb\|EAT40234.1\| cytochr. P450 \[Aa\]
  18603                                                            352            581         318           782          2033        1.53      3.19             gb\|EAT32533.1\| oxidase\[Aa\]
  12532                                                            225            326         152           351          1054        1.35      3.00          gb\|EAU77317.2\| cytochr. P450\[Ag\]
  12429                                                             0             164          0            17         ***181***    152.84     22.09         gb\|ABK97426.1\| 14-3-3 epsilon\[Bm\]
  4356                                                            1757           2396        1330          2962          8445        1.27      2.89             gb\|AAA02748.1\| oxidase \[Dm\]
  3114                                                             416            462         329           545          1752        1.03      2.15          gb\|EAT46755.1\| cytochr.P450 \[Aa\]
  10978                                                            609            496         337           536          1978        0.75      2.07           gb\|EDS44734.1\| esterase B1 \[Cq\]
  10811                                                            574            610         330           513          2027        0.99      2.01         gb\|EAT40232.1\| cytochrome P450 \[Aa\]
  14692                                                            545            434         244           387          1610        0.74      2.06         gb\|EAT37005.1\| cytochrome P450 \[Aa\]
  8206                                                             562            472         203           404          1641        0.78      2.58           gb\|EDS31351.1\| peroxidase \[Cq\]
  **Cytoskeleton and cell adhesion**                                                                                                                   
  14827                                                             0             304          0            50            354      283.32\*   64.97\*       gb\|EAA09442.4\| microtubule BP \[Ag\]
  5354                                                              0             253          1            99            353      235.79\*   128.63        gb\|EAT47479.1\| myosin H-chain \[Ag\]
  16374                                                            56             26           5            35         ***122***     0.43      9.09         gb\|EAT42758.1\| myosin H-chain \[Ag\]
  39386                                                           5590           3493        1758          3235          14076       0.58      2.39         gb\|EAA43613.3\| myosin H-chain \[Ag\]
  19562                                                           1886           1183         628          1210          4907        0.58      2.50         gb\|EAA43613.3\| myosin H-chain \[Ag\]
  3055                                                             180            559         113           725          1577        2.89      8.33         gb\|EAT42933.1\| myosin L-chain \[Aa\]
  12618                                                            170            442         137           509          1258        2.42      4.82         gb\|EDS45745.1\| myosin L-chain \[Cq\]
  38163                                                             0             73           0            31         ***104***    68.03      40.28          gb\|EEB15484.1\| paramyosin \[Phc\]
  4689                                                              0             111          0            51         ***162***    103.45     66.27           gb\|AAA56881.1\| actin 1D \[Ag\]
  26092                                                            165            308         109           362           944        1.73      4.31     gb\|EAL38580.4\| actin-binding activator \[Ag\]
  8662                                                             15             120         19            114        ***268***     7.45      7.79         gb\|EAT41026.1\| stretchin-mlck \[Aa\]
  34885                                                             8             52           2            56         ***118***     6.05      36.38       gb\|AAF58087.2\| stretchin-mlck-D \[Dm\]
  4450                                                             15             109         14            80         ***218***     6.77      7.42        gb\|AAF58087.2\| stretchin-mlck-D \[Dm\]
  21446                                                            35             34           7            34         ***110***     0.90      6.31         gb\|EAT41026.1\| stretchin-mlck \[Aa\]
  7262                                                             67            1856         261          1984          4168       25.82      9.87             gb\|EAA10802.5\| troponin\[Ag\]
  5116                                                             56             45          13            55         ***169***     0.75      5.49            gb\|EAT48765.1\| cadherin \[Aa\]
  2452                                                            10325          6671        4525          7264          28785       0.60      2.09             gb\|EAT45935.1\| kakapo \[Aa\]
  2020                                                            2823           4398        3775          7178          18174       1.45      2.47         gb\|ACJ10211.1\| aminopeptidase N\[Ag\]
  127                                                             3457           3522        2562          4142          13683       0.95      2.10          gb\|EDS25698.1\| calsyntenin-1 \[Cq\]
  722                                                             5514           3851        1642          3053          14060       0.65      2.42         gb\|EAT43208.1\| myosin L-chain \[Aa\]
  693                                                             2329           2616        1280          2330          8555        1.05      2.37            gb\|EAA07720.5\| cadherin \[Ag\]
  2560                                                            2051           1764        1319          2070          7204        0.80      2.03           gb\|EDS41979.1\| myosin-VIIa \[Cq\]
  1270                                                            2471           1661         808          1373          6313        0.62      2.21              gb\|AAS65018.1\| mucin \[Dm\]
  25771                                                            576           1014         474          1040          3104        1.64      2.85         gb\|EAT41121.1\| aminopeptidase \[Aa\]
  4345                                                             973            683         497           909          3062        0.65      2.38            gb\|EDW70354.1\| cadherin \[Dv\]
  8316                                                             726            827         486           892          2931        1.06      2.38            gb\|EAL40462.3\| cadherin \[Ag\]
  2453                                                             751            961         488           828          3028        1.19      2.20            gb\|EAT45302.1\| caspase-1 \[Aa\]
  39406                                                           1322            824         459           820          3425        0.58      2.32          gb\|EAA43613.3\| myosin H-chain\[Ag\]
  48089                                                           1225            802         395           778          3200        0.61      2.56         gb\|EDS44962.1\| myosin H-chain \[Cq\]
  35309                                                            503            668         413           734          2318        1.23      2.31         gb\|EAT42696.1\| aminopeptidase \[Aa\]
  51964                                                            954            606         403           704          2667        0.59      2.27        gb\|EDS33424.1\| spectrin α-chain \[Cq\]
  16375                                                           1160            782         368           694          3004        0.62      2.45         gb\|EDW64148.1\| myosin H-chain \[Dv\]
  49526                                                           1383            513         377           650          2923        0.35      2.24          gb\|EAA43613.3\| myosin H-chain\[Ag\]
  2649                                                            1120            510         291           664          2585        0.42      2.96          gb\|AAF58087.2\| stretchin-mlck\[Dm\]
  14255                                                            578            495         366           569          2008        0.80      2.02       gb\|EAT36338.1\| cell adhesion mol. \[Aa\]
  2742                                                             574            450         351           574          1949        0.73      2.12       gb\|EAT39367.1\| cell adhesion mol. \[Aa\]
  2087                                                             512            581         320           593          2006        1.06      2.41           gb\|EAT39611.1\| myosin vii \[Aa\]
  14852                                                            953            484         210           470          2117        0.47      2.90            gb\|EAT46231.1\| myomesin \[Aa\]
  5560                                                             383            362         258           416          1419        0.88      2.10             gb\|EDO63657.1\| myosin \[Ag\]
  14827                                                             0             304          0            50            354       283.32     64.97        gb\|EAA09442.4\| microtubule BP \[Ag\]
  5354                                                              0             253          1            99            353       235.79    128.63        gb\|EAT47479.1\| myosin H-chain \[Ag\]
  16374                                                            56             26           5            35         ***122***     0.43      9.09         gb\|EAT42758.1\| myosin H-chain \[Ag\]
  39386                                                           5590           3493        1758          3235          14076       0.58      2.39         gb\|EAA43613.3\| myosin H-chain \[Ag\]
  19562                                                           1886           1183         628          1210          4907        0.58      2.50         gb\|EAA43613.3\| myosin H-chain \[Ag\]
  3055                                                             180            559         113           725          1577        2.89      8.33         gb\|EAT42933.1\| myosin L-chain \[Aa\]

10.1371/journal.pone.0089473.t006

###### A list of 20 infection-suppressed contigs for immunity, cell adhesion, and oxidative stress proteins.
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  UIDB contig             Original read\#   RA~ID/UD~   RA~IB/UB~   BLAST results                             
  ---------------------- ----------------- ----------- ----------- --------------- ----------- ------- ------ -------------------------------------------------
  **Immunity**                                                                                                
  17359                        2472           1219        1320          1639          6650      1.61    0.46       gb\|EAL40577.4\| ANK repeat pr. \[Ag\]
  11526                         342            67          67            43            519      0.18    0.84       gb\|EAA05854.4\| ANK repeat pr. \[Ag\]
  4877                          16             34          49             4         ***103***   2.00    0.11      gb\|EAA13974.3\| G-nucleotide-BPγ \[Ag\]
  12518                          5             58          73             0         ***136***   11.11   0.00       gb\|EAA00858.4\| G-nucleotide-BP \[Ag\]
  3493                          76             373        1002           16           1467      4.76    0.02          gb\|AAG54081.1\| arrestin \[Ag\]
  517                           130            835        1525           31           2521      6.25    0.03   gb\|EAA10755.2\| arrestin 2-like protein \[Ag\]
  22758                         75             48          56             8         ***187***   0.60    0.19             gb\|EAT37101.1\| SP \[Aa\]
  6751                         3235           1414        1659          1356          7664      0.41    1.06             gb\|ABE97919.1\| SP \[Ad\]
  7395                         1324            477         514           197          2512      0.50    0.34        gb\|ABF18223.1\| hemolymph pr. \[Aa\]
  2706                          301           2168        1069           170          3708      6.67    0.21           gb\|EAA08853.4\| CLIPC7 \[Ag\]
  26579                         238            18          15             8         ***279***   0.07    0.69      gb\|EAA04533.4\| LRR protein APL1C \[Ag\]
  38607                        2929           1478        1390           551          6348      0.47    0.52     gb\|EAU75744.2\| LRR transmembr. pr. \[Ag\]
  27840                         920            274         313           190          1697      0.28    0.79            gb\|AAR05800.1\| ICHIT \[Ag\]
  **Cell adhesion**                                                                                           
  302                          1132            527         553           802          3014      0.43    1.89           gb\|EAA12983.4\| kakapo \[Ag\]
  27643                         78             11          17            31         ***137***   0.13    2.38            gb\|AAN10358.5\| dumpy \[Dm\]
  20370                         107            21          28            43         ***199***   0.18    2.00        gb\|EAA00978.5\| AGAP001632-PA \[Ag\]
  729                          3427           1704         932          1608          7671      0.46    2.27           gb\|EAT40358.1\| calmin \[Aa\]
  7805                         1621            350         437           278          2686      0.20    0.83   gb\|EAA11173.3\| peritrophic matrix pr. \[Ag\]
  13513                         57              9           6            28         ***100***   0.15    6.25          gb\|EDS27643.1\| rhomboid \[Cq\]
  **Oxidative stress**                                                                                        
  30351                         137             5          12             3         ***157***   0.03    0.33       gb\|EGK96893.1\| cytochrome P450 \[Ag\]

### 4.2. Other up-regulated immunity-related genes {#s3d2}

Similarly, nine PPO contigs (7548, 10561, 24062, 18477, 29061, 24063, 39231, 3605, 3163) were up-regulated in infected mosquitoes ([Table 5](#pone-0089473-t005){ref-type="table"}). There are over 20 PPOs identified in *Ae. aegypti*, *An. gambiae*, *An. stephensi*, *An. culicifacies* and *Ar. subalbatus*, with multiple PPOs in each species [@pone.0089473-Christensen1]. We also found three SP contigs were induced by parasite infection (contigs 479, 20619, 2323). Several intracellular proteins possibly involved in signal transduction/modulation. These include two GTP/GDP exchange factors, two ANK proteins and one MAPK. One defensin (contig 22126, RA~ID/UD~: 3.09) was up-regulated in P. yoelii-infected mosquitoes, which was down-regulated after nitroquine treatment.

### 4.3. Oxidative stress and detoxification proteins {#s3d3}

Ten oxidative stress-responsive and detoxification genes were up-regulated: 7 cytochrome oxidase contigs (37606, 10946, 12511, 12532, 3114, 10811, 14692), a peroxidase (contig 18603), an oxidase (contig 4356), an esterase (contig 10978) and a 14-3-3 epsilon protein (contig 12429). Reactive oxidative species (ROS) can cause cell damage and, hence, are rapidly inactivated in cells by oxygen scavengers and reduction reactions. The inactivation is facilitated by enzymes such as peroxidases and cytochrome c [@pone.0089473-Turrens1]. It is intriguing that transcription of these enzymes was down-regulated after nitroquine treatment but up-regulated in P. yoelii-infected mosquitoes, indicating that nitroquine may suppress the production of these enzymes. Insufficient reduction of ROS may cause damage in parasite by reacting with its lipids, proteins, and nucleic acids. The imbalance of free radical-generating and -scavenging mechanisms then led to loss of homeostasis and Plasmodium death. The involvement of ROS in mosquito immunity against bacteria and Plasmodium was investigated in the malaria vector An. gambiae [@pone.0089473-Molina1]. The production of ROS is thought to contribute to the refractory phenotype, as experimentally elevating ROS in susceptible mosquitoes makes them more refractory [@pone.0089473-Oliveira1]. Similarly, a variety of synthetic insecticides are known to suppress the activity of key reducing enzymes [@pone.0089473-Papadopoulos1]--[@pone.0089473-Wu1].

### 4.4. Cytoskeleton and cell adhesion molecules {#s3d4}

Several induced proteins involved in cytoskeleton formation and cell adhesion, including one microtubule binding protein (contig 14827, RA~ID/UD~: 283.32) and seven myosin-related contigs (5354, 16374, 39386, 19562, 3055, 12618, 38163). Myosin was identified as microtubule binding protein by co-sedimentation analysis in the presence of microtubules [@pone.0089473-Cao1]. Two actin-related protein contigs (4689, 26092) and four stretchin-mlck contigs (8662, 4450, 34885, 21446) were also induced. Members of the titin/myosin light chain kinase family play essential roles in organization of the actin/myosin cytoskeleton, especially in sarcomere assembly and function [@pone.0089473-Champagne1].

5. Genes Suppressed by Plasmodium Infection {#s3e}
-------------------------------------------

Interestingly, while certain immunity-related genes were induced by nitroquine treatment, some of them were down-regulated upon *P. yoelii* infection. For instance, APL1C (contig 26579) and LRR protein (contig 38607) had RA~ID/UD~ of 0.07 and 0.47, respectively. CLIPC7 (contig 2706, RA~IB/UB~: 0.21), three SP contigs (7395, 22758, 6751), two ANK contigs (17359, 11526), two arrestin contigs (517, 3493), and two guanine nucleotide-binding protein contigs (4877, 12518) showed similar patterns of gene suppression. In addition, contig 27840 (RA~ID/UD~: 0.28) encodes ICHIT, whose two chitin-binding domains are linked by a Thr-rich linker. The protein, induced by both bacteria and malaria parasite infection [@pone.0089473-Dimopoulos1], may associate with peritrophic matrix, a chitinous sac separating blood meal from midgut epithelial cells.

The high oocyst number in midgut ([Fig. S2](#pone.0089473.s002){ref-type="supplementary-material"}) and the RAs of infection-affected genes suggest that *P. yoelii* (By265) and *An. stephensi* (Hor) form a highly compatible vector-parasite pair in which the host immune system is no longer effective. Jaramillo-Gutierrez et al. [@pone.0089473-JaramilloGutierrez1] showed that silencing several genes involved in oxidative (OXR1 and GSTT1) or immune (LRIM1 and CTL4) responses had no effect on *P. yoelii* (17XNL) infection of *An. stephensi* (Nijmegen Sda500). In this study, nitroquine induced immune responses of *An. stephensi* (Hor) by unknown mechanism. In nitroquine-treated mosquitoes, mRNA levels of TEP1, APL1C (contig 26579), and other LRR proteins (contigs 38607, 695, and 51750) increased ([Table 3](#pone-0089473-t003){ref-type="table"}). The *Plasmodium* infection induced FREPs, TEP2, and other PRRs ([Table 5](#pone-0089473-t005){ref-type="table"}) but suppressed APL1C (contig 26579) and the LRR protein (contig 38607) ([Table 6](#pone-0089473-t006){ref-type="table"}). While these observations are interesting, we cannot conclude whether this fluctuation of different PRR mRNA levels is responsible for the reduction of *P. yoelii* infectivity in nitroquine-treated mosquitoes. Functional data from RNAi experiments may inform us more on the roles of these PRRs in governing the fate of *P. yoelii* in the mosquito. We are also cautioned by the opposite effects of chloroquine and nitroquine on mosquito response to *Plasmodium* infection, as well as the differences caused by sampling time and method of drug administration. It is desirable to assess whether chloroquine, nitroquine, and other antimalarial drugs have similar effects on the mosquito response at malaria endemic regions.

Conclusion {#s4}
==========

Our study shows nitroquine has a significant impact on transcript abundances of certain mosquito genes implicated in defense against *Plasmodium*, which encode pathogen recognition receptors, signal transducers/modulators, and cytoskeleton-, adhesion-, and oxidative stress- related proteins. Such changes may stimulate the innate immune system of *An. stephensi* to fight *P. yoelii* infection. Even though we do not understand the mechanisms of this drug effect, its impact on the mosquito is evident from the present and previous studies. Together, the results suggest nitroquine induces the production of LRIM1/APL1C/TEP1 complex and down- regulation of enzymes involved in ROS reduction, enhances the attack on parasites, and decreases the *Plasmodium* infectivity. Mechanisms for the infectivity decrease may be distinct, when the time or method of nitroquine administration is different.
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